US Patent 8981084 Oxadiazole HDAC inhibitors

Patent 8981084 was granted and assigned to Tempero Pharmaceuticals, Inc. on March, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Tempero Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

89810840

Patent Inventor Names

Darby Schmidt0

Erkan Baloglu0

Mercedes Lobera0

Shomir Ghosh0

Date of Patent

March 17, 2015

Patent Application Number

135220700

Date Filed

January 13, 2011

Patent Citations Received

‌

US Patent 11958845 Heterocyclic compound

Patent Primary Examiner

Emily Bernhardt

Patent abstract

Disclosed are compounds having the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8981084 Oxadiazole HDAC inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API